Ustekinumab in pediatric patients with Crohn's disease: safety, and efficacy results from a multicenter retrospective study in China

• Главные авторы: Ping Li (Автор), Lin Wang (Автор), Zifei Tang (Автор), Yuhuan Wang (Автор), Zhanju Liu (Автор), Wensong Ge (Автор), Ying Huang (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2024-04-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

BackgroundUstekinumab (UST) is approved as an effective therapy for Crohn's disease (CD) in adults. Off-label use is increasing in the pediatric population, more data on safety and efficacy in pediatric patients with CD is urgently needed.AimsThis study aimed to evaluate the clinical efficacy a...